ArticleiSciencePublished
Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment
Regional connection
Verified Author affiliations on the Europe PMC record name University of Pennsylvania, The Wistar Institute. Affiliation source
- Institutions
- University of Pennsylvania, The Wistar Institute
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- iScience
- Published
- Topic
- Disease research
- Subject terms
- Cancer; Therapeutics
- PubMed ID
- 41704766
- PubMed Central ID
- PMC12907876
- Open access
- Yes, open
- Added to directory
- Source checked